Frédéric Triebel
Director Técnico/Científico/I+D en IMMUTEP LIMITED .
Fortuna: 3 M $ al 31/05/2024
Perfil
Frédéric Triebel is the founder.
He founded Immutep SAS in 2001 and holds the title of Co-Chief Executive Officer.
Currently, Dr. Triebel is the Executive Director & Chief Scientific Officer at Immutep Ltd.
since 2014.
Dr. Triebel's former positions include Director at Institut National de la Santé & de la Recherche Médicale from 1991 to 1996, Professor at Université de Paris IV Paris-Sorbonne, and Principal at IGREC SASU.
Dr. Triebel obtained a doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUTEP LTD
0.73% | 22/08/2023 | 8 653 764 ( 0.73% ) | 3 M $ | 31/05/2024 |
Cargos activos de Frédéric Triebel
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUTEP LIMITED | Director Técnico/Científico/I+D | 12/12/2014 |
Immutep SAS
 Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Director Ejecutivo | 14/07/2016 |
Antiguos cargos conocidos de Frédéric Triebel.
| Empresas | Cargo | Fin |
|---|---|---|
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Director/Miembro de la Junta | 01/01/1996 |
| Université de Paris IV Paris-Sorbonne | Corporate Officer/Principal | - |
IGREC SASU
 IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Corporate Officer/Principal | - |
Formación de Frédéric Triebel.
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Empresas privadas | 4 |
|---|---|
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Health Technology |
IGREC SASU
IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Commercial Services |
| Université de Paris IV Paris-Sorbonne | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
- Bolsa de valores
- Insiders
- Frédéric Triebel
